Buchumschlag

Off-label use of IV t-PA in patients with intracranial neoplasm and cavernoma

Background:The safety of systemic thrombolysis in patients with intracranial tumor and cavernoma are unknown. So far evidence is limited to a number of case reports and few case series or unspecified data based on population-based analysis. Our aim was to comprehend the risk of systemic thrombolysis...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Schwarzbach, Christopher Jan (VerfasserIn) , Ebert, Anne (VerfasserIn) , Hennerici, Michael G. (VerfasserIn) , Neumaier-Probst, Eva (VerfasserIn) , Platten, Michael (VerfasserIn) , Fatar, Marc (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: February 5, 2018
In: Therapeutic advances in neurological disorders
Year: 2018, Jahrgang: 11
ISSN:1756-2864
DOI:10.1177/1756285617753423
Online-Zugang:Verlag, kostenfrei, Volltext: http://dx.doi.org/10.1177/1756285617753423
Verlag, kostenfrei, Volltext: https://doi.org/10.1177/1756285617753423
Volltext
Verfasserangaben:Christopher Jan Schwarzbach, Anne Ebert, Michael G. Hennerici, Eva Neumaier-Probst, Michael Platten and Marc Fatar

MARC

LEADER 00000caa a2200000 c 4500
001 1572175079
003 DE-627
005 20230426124248.0
007 cr uuu---uuuuu
008 180419s2018 xx |||||o 00| ||eng c
024 7 |a 10.1177/1756285617753423  |2 doi 
035 |a (DE-627)1572175079 
035 |a (DE-576)502175079 
035 |a (DE-599)BSZ502175079 
035 |a (OCoLC)1263973104 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Schwarzbach, Christopher Jan  |d 1983-  |e VerfasserIn  |0 (DE-588)1025896726  |0 (DE-627)725502355  |0 (DE-576)37088065X  |4 aut 
245 1 0 |a Off-label use of IV t-PA in patients with intracranial neoplasm and cavernoma  |c Christopher Jan Schwarzbach, Anne Ebert, Michael G. Hennerici, Eva Neumaier-Probst, Michael Platten and Marc Fatar 
264 1 |c  February 5, 2018 
300 |a 6 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 19.04.2018 
520 |a Background:The safety of systemic thrombolysis in patients with intracranial tumor and cavernoma are unknown. So far evidence is limited to a number of case reports and few case series or unspecified data based on population-based analysis. Our aim was to comprehend the risk of systemic thrombolysis in these patients.Methods:Patients with additional evidence of intracranial tumor or cavernoma who received IV tissue plasminogen activator (t-PA) treatment at our comprehensive stroke center over a period of 7 years were identified in our stroke database and compared to the same number of matched control subjects without any evidence of intracranial tumor and cavernoma. Clinical history and imaging patterns before and after t-PA therapy were individually reviewed for each patient.Results:Thirty-four patients with additional evidence of meningioma (19/34), cavernoma (13/34) or malignant intracranial neoplasm (2/34) were identified. The incidence of secondary intracranial hemorrhage observed showed no difference between control subjects (9/34, 26%) and patients (6/34, 18%; p = 0.56). Symptomatic hemorrhage in patients with meningioma or cavernoma could not be observed. Likewise, the prevalence of stroke mimics showed no difference between patients (8/34, 24%) and control subjects (5/34, 15%; p = 0.54). However, both patients with malignant intracranial neoplasm presented with a stroke mimic and intracranial hemorrhage was observed in one of them.Conclusions:In compliance with existing evidence, treatment in patients with meningioma and cavernoma appears to be safe and reasonable, while the therapy should be avoided in patients with malignant intracranial neoplasm with blood?brain barrier disruption. 
700 1 |a Ebert, Anne  |d 1971-  |e VerfasserIn  |0 (DE-588)122028635  |0 (DE-627)081691998  |0 (DE-576)175098344  |4 aut 
700 1 |a Hennerici, Michael G.  |d 1948-  |e VerfasserIn  |0 (DE-588)11587545X  |0 (DE-627)077527704  |0 (DE-576)290126444  |4 aut 
700 1 |a Neumaier-Probst, Eva  |d 1958-  |e VerfasserIn  |0 (DE-588)1053183933  |0 (DE-627)789663597  |0 (DE-576)408942150  |4 aut 
700 1 |a Platten, Michael  |d 1971-  |e VerfasserIn  |0 (DE-588)121627780  |0 (DE-627)081431848  |0 (DE-576)261969811  |4 aut 
700 1 |a Fatar, Marc  |d 1972-  |e VerfasserIn  |0 (DE-588)12250108X  |0 (DE-627)705931501  |0 (DE-576)293298963  |4 aut 
773 0 8 |i Enthalten in  |t Therapeutic advances in neurological disorders  |d London [u.a.] : Sage, 2008  |g 11(2018)  |h Online-Ressource  |w (DE-627)573753849  |w (DE-600)2442245-9  |w (DE-576)305897357  |x 1756-2864  |7 nnas  |a Off-label use of IV t-PA in patients with intracranial neoplasm and cavernoma 
773 1 8 |g volume:11  |g year:2018  |g extent:6  |a Off-label use of IV t-PA in patients with intracranial neoplasm and cavernoma 
856 4 0 |u http://dx.doi.org/10.1177/1756285617753423  |x Verlag  |x Resolving-System  |z kostenfrei  |3 Volltext 
856 4 0 |u https://doi.org/10.1177/1756285617753423  |x Verlag  |z kostenfrei  |3 Volltext 
951 |a AR 
992 |a 20180419 
993 |a Article 
994 |a 2018 
998 |g 12250108X  |a Fatar, Marc  |m 12250108X:Fatar, Marc  |d 60000  |d 62700  |e 60000PF12250108X  |e 62700PF12250108X  |k 0/60000/  |k 1/60000/62700/  |p 6  |y j 
998 |g 121627780  |a Platten, Michael  |m 121627780:Platten, Michael  |d 60000  |d 62700  |e 60000PP121627780  |e 62700PP121627780  |k 0/60000/  |k 1/60000/62700/  |p 5 
998 |g 1053183933  |a Neumaier-Probst, Eva  |m 1053183933:Neumaier-Probst, Eva  |d 60000  |d 63000  |e 60000PN1053183933  |e 63000PN1053183933  |k 0/60000/  |k 1/60000/63000/  |p 4 
998 |g 11587545X  |a Hennerici, Michael G.  |m 11587545X:Hennerici, Michael G.  |d 60000  |e 60000PH11587545X  |k 0/60000/  |p 3 
998 |g 122028635  |a Ebert, Anne  |m 122028635:Ebert, Anne  |d 60000  |d 62700  |e 60000PE122028635  |e 62700PE122028635  |k 0/60000/  |k 1/60000/62700/  |p 2 
998 |g 1025896726  |a Schwarzbach, Christopher Jan  |m 1025896726:Schwarzbach, Christopher Jan  |d 60000  |d 62700  |e 60000PS1025896726  |e 62700PS1025896726  |k 0/60000/  |k 1/60000/62700/  |p 1  |x j 
999 |a KXP-PPN1572175079  |e 3006464591 
BIB |a Y 
SER |a journal 
JSO |a {"type":{"media":"Online-Ressource","bibl":"article-journal"},"language":["eng"],"note":["Gesehen am 19.04.2018"],"title":[{"title_sort":"Off-label use of IV t-PA in patients with intracranial neoplasm and cavernoma","title":"Off-label use of IV t-PA in patients with intracranial neoplasm and cavernoma"}],"origin":[{"dateIssuedKey":"2018","dateIssuedDisp":" February 5, 2018"}],"person":[{"display":"Schwarzbach, Christopher Jan","family":"Schwarzbach","role":"aut","given":"Christopher Jan"},{"family":"Ebert","role":"aut","given":"Anne","display":"Ebert, Anne"},{"display":"Hennerici, Michael G.","given":"Michael G.","role":"aut","family":"Hennerici"},{"display":"Neumaier-Probst, Eva","given":"Eva","role":"aut","family":"Neumaier-Probst"},{"family":"Platten","given":"Michael","role":"aut","display":"Platten, Michael"},{"display":"Fatar, Marc","role":"aut","given":"Marc","family":"Fatar"}],"relHost":[{"disp":"Off-label use of IV t-PA in patients with intracranial neoplasm and cavernomaTherapeutic advances in neurological disorders","recId":"573753849","physDesc":[{"extent":"Online-Ressource"}],"part":{"text":"11(2018)","volume":"11","extent":"6","year":"2018"},"title":[{"title":"Therapeutic advances in neurological disorders","title_sort":"Therapeutic advances in neurological disorders"}],"id":{"eki":["573753849"],"issn":["1756-2864"],"zdb":["2442245-9"]},"language":["eng"],"type":{"bibl":"periodical","media":"Online-Ressource"},"pubHistory":["1.2008 -"],"origin":[{"publisher":"Sage","publisherPlace":"London [u.a.]","dateIssuedKey":"2008","dateIssuedDisp":"2008-"}]}],"physDesc":[{"extent":"6 S."}],"recId":"1572175079","id":{"eki":["1572175079"],"doi":["10.1177/1756285617753423"]},"name":{"displayForm":["Christopher Jan Schwarzbach, Anne Ebert, Michael G. Hennerici, Eva Neumaier-Probst, Michael Platten and Marc Fatar"]}} 
SRT |a SCHWARZBACOFFLABELUS5201 

Ähnliche Einträge